Literature DB >> 7528761

Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF.

J Morisset1, F L Bérubé, M Vanier, O Benrezzak.   

Abstract

Reserpine treatment resulted in altered enzyme secretion from rat pancreatic acini in response to carbamylcholine and secretin (1,2). This study was undertaken: (1) To evaluate if the alterations caused by reserpine can be prevented by EGF and/or cerulein treatments; (2) To determine the time-course of secretion recovery after reserpine treatment; and (3) To establish if EGF and/or cerulein treatments can accelerate such a recovery after the reserpine treatment. Male Sprague-Dawley rats (250-265 g) were used in these experiments. In experiment I, rats divided into three groups received either reserpine (R) or the reserpine vehicle for the controls (C) and the pair-fed controls (PF) for 7 d. During treatment, PF and R rats were given SC, twice a day, saline, EGF (10 micrograms/kg), cerulein (1 microgram/kg), or both at the same dose. C rats received saline in gelatin. In experiment II, rats were treated for 7 d with reserpine or the vehicle as described in experiment I, were allowed a 30-d recovery period and then were killed. In experiment III, C, PF, and R rats were treated for 7 d as described in experiment I; on the 8th d and for the next 6 d, reserpine rats received saline (reserpine-saline), cerulein, EGF, or both cerulein +EGF at the same dose as indicated in experiment I. C and PF rats received saline in gelatin. After sacrifice, acini were prepared, and amylase dose-response curves to carbamylcholine (Cch) and secretin were established. EGF, cerulein, or their combination given to R rats did not improve the desensitized secretory response to Cch.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528761     DOI: 10.1007/bf02925608

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  28 in total

1.  A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions.

Authors:  M Ceska; K Birath; B Brown
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

2.  Muscarinic cholinergic induced secretin subsensitivity in rat isolated pancreatic acini. Effects on amylase release, cyclic adenosine monophosphate and inositol phosphate formation.

Authors:  L Larose; L Leclerc; J Asselin; S Ruel; J Morisset
Journal:  Pancreas       Date:  1989       Impact factor: 3.327

3.  Interaction of caerulein and secretin on pancreatic size and composition in rat.

Authors:  T E Solomon; H Petersen; J Elashoff; M I Grossman
Journal:  Am J Physiol       Date:  1978-12

4.  The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip.

Authors:  W D Paton; E S Vizi
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

5.  Stimulation of rat oxyntic gland mucosal growth by epidermal growth factor.

Authors:  L R Johnson; P D Guthrie
Journal:  Am J Physiol       Date:  1980-01

6.  Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats.

Authors:  A Dembiński; H Gregory; S J Konturek; M Polański
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

7.  Effects of reserpine treatment on dietary adaptation of the rat exocrine pancreas.

Authors:  D A Hazlett; P M Brannon
Journal:  Pediatr Res       Date:  1988-02       Impact factor: 3.756

8.  Alterations of the pancreatic secretory responses to secretin and to the ionophore A23187 by reserpine: a calcium-mediated phenomenon?

Authors:  O Benrezzak; F L Bérubé; L St-Jean; J Morisset
Journal:  Digestion       Date:  1994       Impact factor: 3.216

9.  Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells.

Authors:  R Casteels; I S Login
Journal:  J Physiol       Date:  1983-07       Impact factor: 5.182

10.  Chronically reserpinized rat as a model for cystic fibrosis: Na+ transport inhibitory effect in submaxillary saliva.

Authors:  J R Martinez; A M Martinez; L Garrett; P Korman
Journal:  Pediatr Res       Date:  1979-10       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.